202 related articles for article (PubMed ID: 30221656)
1. Protection of insulin‑like growth factor 1 on experimental peripheral neuropathy in diabetic mice.
Wang H; Zhang H; Cao F; Lu J; Tang J; Li H; Zhang Y; Feng B; Tang Z
Mol Med Rep; 2018 Nov; 18(5):4577-4586. PubMed ID: 30221656
[TBL] [Abstract][Full Text] [Related]
2. Peripheral pain is enhanced by insulin-like growth factor 1 and its receptors in a mouse model of type 2 diabetes mellitus.
Tang Z; Cao F; Zhang H; Tang J; Li H; Zhang Y; Feng B; Wang H
J Diabetes; 2019 Apr; 11(4):309-315. PubMed ID: 30105862
[TBL] [Abstract][Full Text] [Related]
3. GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats.
Ma J; Shi M; Zhang X; Liu X; Chen J; Zhang R; Wang X; Zhang H
Int J Mol Med; 2018 May; 41(5):2977-2985. PubMed ID: 29484377
[TBL] [Abstract][Full Text] [Related]
4. Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice.
Wang L; Chopp M; Szalad A; Lu X; Jia L; Lu M; Zhang RL; Zhang ZG
PLoS One; 2016; 11(7):e0159665. PubMed ID: 27438594
[TBL] [Abstract][Full Text] [Related]
5. Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3.
Middlemas A; Delcroix JD; Sayers NM; Tomlinson DR; Fernyhough P
Brain; 2003 Jul; 126(Pt 7):1671-82. PubMed ID: 12805110
[TBL] [Abstract][Full Text] [Related]
6. Effects of Alpha Lipoic Acid on Loss of Myelin Sheath of Sciatic Nerve in Experimentally Induced Diabetic Rats.
Tasci I; Demir CF; Kuloglu T
Med Arch; 2018 Jun; 72(3):178-181. PubMed ID: 30061762
[TBL] [Abstract][Full Text] [Related]
7. Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.
Stavniichuk R; Drel VR; Shevalye H; Maksimchyk Y; Kuchmerovska TM; Nadler JL; Obrosova IG
Exp Neurol; 2011 Jul; 230(1):106-13. PubMed ID: 21515260
[TBL] [Abstract][Full Text] [Related]
8. Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, peripheral diabetic polyneuropathy, and the metabolic syndrome.
Nowicki M; Kosacka J; Serke H; Blüher M; Spanel-Borowski K
J Neurosci Res; 2012 Jan; 90(1):122-31. PubMed ID: 21919033
[TBL] [Abstract][Full Text] [Related]
9. GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice.
Jolivalt CG; Fineman M; Deacon CF; Carr RD; Calcutt NA
Diabetes Obes Metab; 2011 Nov; 13(11):990-1000. PubMed ID: 21635674
[TBL] [Abstract][Full Text] [Related]
10. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
Shindo H; Tawata M; Aida K; Onaya T
J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of the active components of ERPC on diabetic peripheral neuropathy in rats.
Hao GM; Liu YG; Wu Y; Xing W; Guo SZ; Wang Y; Wang ZL; Li C; Lv TT; Wang HL; Shi TJ; Wang W; Han J
J Ethnopharmacol; 2017 Apr; 202():162-171. PubMed ID: 28315720
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside treatment of genetic and alloxan-induced diabetic neuropathy.
Gorio A; Aporti F; Di Gregorio F; Schiavinato A; Siliprandi R; Vitadello M
Adv Exp Med Biol; 1984; 174():549-64. PubMed ID: 6204518
[TBL] [Abstract][Full Text] [Related]
13. Taurine protects against myelin damage of sciatic nerve in diabetic peripheral neuropathy rats by controlling apoptosis of schwann cells via NGF/Akt/GSK3β pathway.
Li K; Shi X; Luo M; Inam-U-Llah ; Wu P; Zhang M; Zhang C; Li Q; Wang Y; Piao F
Exp Cell Res; 2019 Oct; 383(2):111557. PubMed ID: 31415759
[TBL] [Abstract][Full Text] [Related]
14. Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
Elias KA; Cronin MJ; Stewart TA; Carlsen RC
Diabetes; 1998 Oct; 47(10):1637-42. PubMed ID: 9753304
[TBL] [Abstract][Full Text] [Related]
15. miR-146a mediates thymosin β4 induced neurovascular remodeling of diabetic peripheral neuropathy in type-II diabetic mice.
Wang L; Chopp M; Lu X; Szalad A; Jia L; Liu XS; Wu KH; Lu M; Zhang ZG
Brain Res; 2019 Mar; 1707():198-207. PubMed ID: 30500399
[TBL] [Abstract][Full Text] [Related]
16. Angelica injection promotes peripheral nerve structure and function recovery with increased expressions of nerve growth factor and brain derived neurotrophic factor in diabetic rats.
Li R; Zhang J; Zhang L; Cui Q; Liu H
Curr Neurovasc Res; 2010 Aug; 7(3):213-22. PubMed ID: 20560879
[TBL] [Abstract][Full Text] [Related]
17. The preventive efficacy of methylcobalamin on rat peripheral neuropathy influenced by diabetes via neural IGF-1 levels.
Jian-bo L; Cheng-ya W; Jia-wei C; Xiao-lu L; Zhen-qing F; Hong-tai M
Nutr Neurosci; 2010 Apr; 13(2):79-86. PubMed ID: 20406575
[TBL] [Abstract][Full Text] [Related]
18. Magnolol effectively ameliorates diabetic peripheral neuropathy in mice.
Yang J; Wei Y; Zhao T; Li X; Zhao X; Ouyang X; Zhou L; Zhan X; Qian M; Wang J; Shen X
Phytomedicine; 2022 Dec; 107():154434. PubMed ID: 36122436
[TBL] [Abstract][Full Text] [Related]
19. The impact of low-dose insulin on peripheral nerve insulin receptor signaling in streptozotocin-induced diabetic rats.
Sugimoto K; Baba M; Suzuki S; Yagihashi S
PLoS One; 2013; 8(8):e74247. PubMed ID: 24023699
[TBL] [Abstract][Full Text] [Related]
20. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
Manschot SM; Gispen WH; Kappelle LJ; Biessels GJ
Diabetes Metab Res Rev; 2003; 19(6):469-77. PubMed ID: 14648806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
